Cargando…

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis

Detalles Bibliográficos
Autores principales:	Vesely, Matthew D., Imaeda, Suguru, King, Brett A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192094/ https://www.ncbi.nlm.nih.gov/pubmed/28050588 http://dx.doi.org/10.1016/j.jdcr.2016.09.008

Ejemplares similares

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021)

Atopic dermatitis: Tofacitinib, an option for refractory disease
por: Berbert Ferreira, Sineida, et al.
Publicado: (2020)

Tofacitinib Citrate for Ulcerative Keratitis in a Patient with Rheumatoid Arthritis
por: Meadow, Philip B., et al.
Publicado: (2014)

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
por: Di Lernia, V, et al.
Publicado: (2016)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Oral tofacitinib citrate for recalcitrant cutaneous lupus
por: Bonnardeaux, Evelyne, et al.
Publicado: (2021)

Treatment of granuloma annulare with tofacitinib 2% ointment
por: Damsky, William, et al.
Publicado: (2019)

Successful treatment of refractory IgA vasculitis with tofacitinib
por: Xu, Yi-Fei, et al.
Publicado: (2022)

Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis
por: Nakamura, Masanao, et al.
Publicado: (2022)

Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
por: Shin, Wonsuk, et al.
Publicado: (2020)

Tofacitinib for refractory ocular mucous membrane pemphigoid
por: James, Hayley, et al.
Publicado: (2021)

Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib
por: Damsky, William E., et al.
Publicado: (2019)

Treatment of Multiorgan Sarcoidosis With Tofacitinib
por: Damsky, William, et al.
Publicado: (2020)

Tofacitinib for the Treatment of Psoriasiform Dermatitis Caused by IL-17 Inhibitors: A Case Report
por: Luo, Nan, et al.
Publicado: (2023)

Microneedle Mediated Iontophoretic Delivery of Tofacitinib Citrate
por: Dandekar, Amruta A., et al.
Publicado: (2022)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
por: Talty, Ronan, et al.
Publicado: (2022)

Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016)

Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
por: Kim, Sa Rang, et al.
Publicado: (2018)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
por: Talty, Ronan, et al.
Publicado: (2021)

Remission of chronic actinic dermatitis on baricitinib: A case report
por: Maguire, Jessica, et al.
Publicado: (2023)

Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: design, development and positioning of therapy
por: Tran, Vivy, et al.
Publicado: (2019)

Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature
por: Chen, Jiaoquan, et al.
Publicado: (2021)

Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2019)

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
por: Yamamura, Yuriko, et al.
Publicado: (2019)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
por: Singh, Katelyn, et al.
Publicado: (2020)

Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
por: Damsky, William, et al.
Publicado: (2016)

Successful use of ustekinumab therapy in refractory severe atopic dermatitis
por: Shroff, Anjali, et al.
Publicado: (2014)

Tofacitinib in Refractory Scleritis: A Case Series
por: Dey, Suvankar, et al.
Publicado: (2023)

A case report of therapeutically challenging chronic actinic dermatitis
por: Verma, Luvneet, et al.
Publicado: (2019)

Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
por: Shahriari, Neda, et al.
Publicado: (2022)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case
por: Wang, Yixin Ally, et al.
Publicado: (2020)

Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
por: Pope, Eleanor, et al.
Publicado: (2022)

Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn’s disease: a case report
por: Nathoo, Sunina, et al.
Publicado: (2016)

Treatment of Resistant Alopecia areata with Tofacitinib
por: Avhad, Ganesh
Publicado: (2022)

Tofacitinib for the Treatment of Steroid-Induced Rosacea
por: Li, Tianhao, et al.
Publicado: (2022)

Strontium citrate associated drug reaction with eosinophilia and systemic symptoms syndrome with granulomatous dermatitis
por: Kolitz, Elysha, et al.
Publicado: (2021)

Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
por: Álvarez-Reguera, Carmen, et al.
Publicado: (2022)

VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib
por: Fahmy, Lauren M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c2ko2feb5l8oqpqvn9o11ihbia